Celebrex, Celecoxib News

TUESDAY, May 29 -- Taking nonsteroidal anti-inflammatory drugs -- which include medicine cabinet staples such as aspirin, Motrin and Aleve -- appears to significantly lower the risk for developing several major forms of skin cancer, a new Danish study reveals.

Q: About 15 years ago, I was diagnosed with osteoarthritis in both knees. I started taking ibuprofen for the pain.

Q: About 15 years ago, I was diagnosed with osteoarthritis in both knees. I started taking ibuprofen for the pain.

The new report* examines how arthritis therapeutics are becoming a gigantic attraction in the global pharmaceutical industry as the condition is increasingly considered to be one of the most common causes of disabilities.

Everyone who realizes or is told they are gluten-intolerant has their own unique story about what led to this realization.

Located just a block away from the Memorial Campus of UMass Memorial Medical Group, Dr.

The once popular cox-2 drugs, Vioxx and Bextra, were pulled off the market in 2004 and 2005, respectively, after research showed that both raised the chances of cardiovascular trouble.

Weeks before a scheduled trial, Pfizer and Brigham Young University have settled a six-year-old lawsuit brought by the university and Daniel L. Simmons, a BYU chemistry professor, over the cyclooxygenase-2, or COX-2, inhibitor that is the active ingredient in Pfizer's Celebrex, the blockbuster painkiller.

Pfizer released first quarter 2012 results on May 1, coming in slightly above analyst expectations despite decreased revenues.

MANHASSET, NY HPV is the most common sexually-transmitted virus in the U.S., but what many don't know is HPV can also cause a serious respiratory disease.

It has been almost eight years since Vioxx was withdrawn by Merck from the market, provoking an intense controversy about the role inhibitors of the enzyme COX-2 play in causing heart attacks and strokes.

More teens are smoking dope, with nearly 1 in 10 lighting up at least 20 or more times a month, according to a new survey of young people.

But a footnote in Pfizer's quarterly financial report released Tuesday refers to a "$450 million charge in connection with an agreement-in-principle to settle a lawsuit by Brigham Young University related to Celebrex." "As part of the resolution, BYU will establish the Dan Simmons Chair in recognition of Dr.